IRIS Accounts Production v24.3.0.553 07185293 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false A Ordinary Shares 1.00000 B Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071852932023-03-31071852932024-03-31071852932023-04-012024-03-31071852932022-03-31071852932022-04-012023-03-31071852932023-03-3107185293ns15:EnglandWales2023-04-012024-03-3107185293ns14:PoundSterling2023-04-012024-03-3107185293ns10:Director12023-04-012024-03-3107185293ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107185293ns10:SmallEntities2023-04-012024-03-3107185293ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107185293ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107185293ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107185293ns10:FullAccounts2023-04-012024-03-310718529312023-04-012024-03-3107185293ns10:OrdinaryShareClass12023-04-012024-03-3107185293ns10:OrdinaryShareClass22023-04-012024-03-3107185293ns5:CurrentFinancialInstruments2024-03-3107185293ns5:CurrentFinancialInstruments2023-03-3107185293ns5:ShareCapital2024-03-3107185293ns5:ShareCapital2023-03-3107185293ns5:RetainedEarningsAccumulatedLosses2024-03-3107185293ns5:RetainedEarningsAccumulatedLosses2023-03-3107185293ns10:RegisteredOffice2023-04-012024-03-3107185293ns5:NetGoodwill2023-04-012024-03-3107185293ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107185293ns5:NetGoodwill2023-03-3107185293ns5:NetGoodwill2024-03-3107185293ns5:NetGoodwill2023-03-3107185293ns5:FurnitureFittings2023-03-3107185293ns5:FurnitureFittings2024-03-3107185293ns5:FurnitureFittings2023-03-3107185293ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107185293ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3107185293ns10:OrdinaryShareClass12024-03-3107185293ns10:OrdinaryShareClass22024-03-31071852931ns10:Director12023-03-31071852931ns10:Director12022-03-31071852931ns10:Director12023-04-012024-03-31071852931ns10:Director12022-04-012023-03-31071852931ns10:Director12024-03-31071852931ns10:Director12023-03-31
REGISTERED NUMBER: 07185293 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st March 2024

for

John Skinner Surgical Ltd

John Skinner Surgical Ltd (Registered number: 07185293)






Contents of the Financial Statements
for the Year Ended 31st March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


John Skinner Surgical Ltd (Registered number: 07185293)

Balance Sheet
31st March 2024

31.3.24 31.3.23
Notes £    £   
CURRENT ASSETS
Debtors 6 2,751 7,203

CREDITORS
Amounts falling due within one year 7 11,440 3,356
NET CURRENT (LIABILITIES)/ASSETS (8,689 ) 3,847
TOTAL ASSETS LESS CURRENT
LIABILITIES

(8,689

)

3,847

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings (8,789 ) 3,747
SHAREHOLDERS' FUNDS (8,689 ) 3,847

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27th December 2024 and were signed on its behalf by:





Dr J A Skinner - Director


John Skinner Surgical Ltd (Registered number: 07185293)

Notes to the Financial Statements
for the Year Ended 31st March 2024

1. COMPANY INFORMATION

John Skinner Surgical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07185293

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Goodwill
Franchise costs, being the amount paid in connection with the acquisition of a business in 2011, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

John Skinner Surgical Ltd (Registered number: 07185293)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

4. INTANGIBLE FIXED ASSETS
Franchise
costs
£   
COST
At 1st April 2023
and 31st March 2024 758,615
AMORTISATION
At 1st April 2023
and 31st March 2024 758,615
NET BOOK VALUE
At 31st March 2024 -
At 31st March 2023 -

5. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st April 2023
and 31st March 2024 1,460
DEPRECIATION
At 1st April 2023
and 31st March 2024 1,460
NET BOOK VALUE
At 31st March 2024 -
At 31st March 2023 -

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
S455 recoverable 648 -
Directors' current accounts - 7,203
Tax 2,103 -
2,751 7,203

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Tax 475 2,752
Directors' current accounts 10,281 -
Accrued expenses 684 604
11,440 3,356

John Skinner Surgical Ltd (Registered number: 07185293)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
60 A Ordinary Shares 1 60 60
40 B Ordinary Shares 1 40 40
100 100

The ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in respect of dividend and capital distribution rights.

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2024 and 31st March 2023:

31.3.24 31.3.23
£    £   
Dr J A Skinner
Balance outstanding at start of year 7,203 178
Amounts advanced - 17,113
Amounts repaid (17,483 ) (10,088 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (10,280 ) 7,203

The loan is payable on demand and no interest was charged during the year.

10. CONTROL

The ultimate controlling party is Dr J A Skinner.